Condition:1 | Methylene tetrahydrofolate reductase deficiency |
---|---|
SNOMED CT Code:3 | 41797007—5,10-Methylenetetrahydrofolate reductase deficiency UMLS CUI:4C0268615 |
ICD-9-CM Code:5 | 270.4—Disturbances of sulphur-bearing amino-acid metabolism |
ICD-10-CM Code:6 | E72.12—Methylenetetrahydrofolate reductase deficiency |
Deficiency, deficient. methylenetetrahydrofolate reductase E72.12 (MTHFR) Disorder (of) - see also Disease. metabolism NOS E88.9. ICD-10-CM Diagnosis Code E88.9. Metabolic disorder, unspecified. 2016 2017 2018 2019 2020 2021 Billable/Specific Code. amino-acid E72.9. ICD-10-CM Diagnosis Code E72.9.
Methylenetetrahydrofolate reductase mutation. ICD-10-CM E72.12 is grouped within Diagnostic Related Group (s) (MS-DRG v38.0): 642 Inborn and other disorders of metabolism. Convert E72.12 to ICD-9-CM.
Hereditary deficiency of other clotting factors. D68.2 is a billable/specific ICD-10-CM code that can be used to indicate a diagnosis for reimbursement purposes. The 2019 edition of ICD-10-CM D68.2 became effective on October 1, 2018. This is the American ICD-10-CM version of D68.2 - other international versions of ICD-10 D68.2 may differ.
2018/2019 ICD-10-CM Diagnosis Code E83.110. Hereditary hemochromatosis. 2016 2017 2018 2019 Billable/Specific Code. E83.110 is a billable/specific ICD-10-CM code that can be used to indicate a diagnosis for reimbursement purposes.
The 2022 edition of ICD-10-CM D68. 51 became effective on October 1, 2021. This is the American ICD-10-CM version of D68.
Homocystinuria due to MTHFR deficiency is a genetic condition that results from poor metabolism of folate (also called vitamin B9), due to a lack of working enzyme called MTHFR. The gene that tells our body how to make the enzyme is also called MTHFR.
E7212 - ICD 10 Diagnosis Code - Methylenetetrahydrofolate reductase deficiency - Market Size, Prevalence, Incidence, Quality Outcomes, Top Hospitals & Physicians.
Hereditary deficiency of other clotting factors The 2022 edition of ICD-10-CM D68. 2 became effective on October 1, 2021. This is the American ICD-10-CM version of D68.
Some people have a genetic mutation in 1 or both of their MTHFR genes. People with a mutation in 1 MTHFR gene are are said to be heterozygous; if mutations are present in both genes, the person is said to be homozygous or compound heterozygous for the mutation(s).
During pregnancy, women who test positive for a mutated MTHFR gene may have a higher risk for miscarriages, preeclampsia, or a baby born with birth defects, such as spina bifida. Here's what you need to know about getting tested for this gene and how it might affect your pregnancy.
Names and CodesCondition:1Methylene tetrahydrofolate reductase deficiencySNOMED CT Code:341797007—5,10-Methylenetetrahydrofolate reductase deficiency UMLS CUI:4C0268615ICD-9-CM Code:5270.4—Disturbances of sulphur-bearing amino-acid metabolismICD-10-CM Code:6E72.12—Methylenetetrahydrofolate reductase deficiency2 more rows
Chromosomal abnormality, unspecified Q99. 9 is a billable/specific ICD-10-CM code that can be used to indicate a diagnosis for reimbursement purposes. The 2022 edition of ICD-10-CM Q99. 9 became effective on October 1, 2021.
There are two common types, or variants, of MTHFR mutations: C677T and A1298C. These gene mutations are relatively common. In fact, in the United States, around 25% of people of Hispanic descent and 10–15% of people of Caucasian descent have two copies of C677T.
Heterozygous means that the 2 copies of a gene are different. In your case, one of your Factor V gene codes is for normal clotting Factor V and the other Factor V gene code is for Factor V Leiden. There is more risk of a blood clot if both gene codes are for Factor V Leiden (ie in the homozygous state).
Group 1CodeDescription81241F5 (COAGULATION FACTOR V) (EG, HEREDITARY HYPERCOAGULABILITY) GENE ANALYSIS, LEIDEN VARIANT81291MTHFR (5,10-METHYLENETETRAHYDROFOLATE REDUCTASE) (EG, HEREDITARY HYPERCOAGULABILITY) GENE ANALYSIS, COMMON VARIANTS (EG, 677T, 1298C)1 more row
A: When physicians use a prothrombin time test (reported with CPT code 85610) to monitor patients on anticoagulant drugs, Medicare pays the entity that performed the test. Its payment for the test is based on the geographically specific laboratory test fee schedule.
Maternal care for unspecified congenital malformation of uterus, third trimester 1 O00-O9A#N#2021 ICD-10-CM Range O00-O9A#N#Pregnancy, childbirth and the puerperium#N#Note#N#CODES FROM THIS CHAPTER ARE FOR USE ONLY ON MATERNAL RECORDS, NEVER ON NEWBORN RECORDS#N#Codes from this chapter are for use for conditions related to or aggravated by the pregnancy, childbirth, or by the puerperium (maternal causes or obstetric causes)#N#Trimesters are counted from the first day of the last menstrual period. They are defined as follows:#N#1st trimester- less than 14 weeks 0 days#N#2nd trimester- 14 weeks 0 days to less than 28 weeks 0 days#N#3rd trimester- 28 weeks 0 days until delivery#N#Type 1 Excludes#N#supervision of normal pregnancy ( Z34.-)#N#Type 2 Excludes#N#mental and behavioral disorders associated with the puerperium ( F53.-)#N#obstetrical tetanus ( A34)#N#postpartum necrosis of pituitary gland ( E23.0)#N#puerperal osteomalacia ( M83.0)#N#Use Additional#N#code from category Z3A, Weeks of gestation, to identify the specific week of the pregnancy, if known.#N#Pregnancy, childbirth and the puerperium 2 O34#N#ICD-10-CM Diagnosis Code O34#N#Maternal care for abnormality of pelvic organs#N#2016 2017 2018 2019 2020 2021 Non-Billable/Non-Specific Code#N#Code First#N#any associated obstructed labor ( O65.5)#N#Includes#N#the listed conditions as a reason for hospitalization or other obstetric care of the mother, or for cesarean delivery before onset of labor#N#Use Additional#N#code for specific condition#N#Maternal care for abnormality of pelvic organs 3 O34.0#N#ICD-10-CM Diagnosis Code O34.0#N#Maternal care for congenital malformation of uterus#N#2016 2017 2018 2019 2020 2021 Non-Billable/Non-Specific Code#N#Applicable To#N#Maternal care for double uterus#N#Maternal care for uterus bicornis#N#Maternal care for congenital malformation of uterus
O34.03 is applicable to mothers in the third trimester of pregnancy, which is defined as between equal to or greater than 28 weeks since the first day of the last menstrual period. The following code (s) above O34.03 contain annotation back-references. Annotation Back-References.